Plain-English translation of NCT05968417 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Myeloma research guide →Researchers at the Institute of Cancer Research are looking for better ways to treat myeloma, a cancer of the bone marrow. This study asks patients who are already having blood or bone marrow samples taken for their regular medical care to donate a small additional sample for research. Scientists will use these samples to test promising new treatments in the laboratory and figure out why some patients' myelomas become resistant to current therapies.
Over 5,000 people are diagnosed with myeloma each year in the UK, and current treatments don't work for everyone or can cause difficult side effects. This research aims to discover more effective treatments with fewer side effects by understanding how the disease develops and why it sometimes stops responding to medication.
You likely qualify if…
You likely don't qualify if…
If you qualify, you'll be asked to provide one additional blood or bone marrow sample at the time you're already scheduled to have these tests done for your diagnosis or treatment follow-up. This means no extra visits — the research sample is collected during your routine medical appointment. Your samples will be tested in the laboratory to help researchers understand which new treatments might work best for myeloma and why some patients develop resistance to current drugs.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
United Kingdom
Sponsor
Institute of Cancer Research, United Kingdom
Collaborators
Royal Marsden NHS Foundation Trust
Enrollment target
~250 participants
Started
July 2020
Primary completion
February 2033
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Disco Team
Institute of Cancer Research, United Kingdom
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.